Our Mission
To empower cancer patients with:
- Ownership and control of their fundamental genomic and health data
- Tools to analyze that data efficiently and make it readily available to their advisor
- Information and expertise that allow them to discover, explore and access a variety of the most current personalized therapeutic options for their own care
Our Mission
- Ownership and control of their fundamental genomic and health data
- Tools to analyze that data efficiently and make it readily available to their advisors
- Information and expertise that allow them to discover, explore and access a variety of the most current personalized therapeutic options for their own care
Our Story
Diagnosed with Stage IV esophageal cancer, Stephen was given just four months to live. In search of treatment options, he sequenced his whole exome genome and used the data to identify and obtain access to novel immunotherapies including a personalized neoantigen vaccine.
He survived and thrived for three full years beyond expectations, and it became his mission to bring his approach to the masses.
Stephen passed away in July, 2020, due to complications from radiation treatments, not from the cancer itself. His loss only strengthens our resolve to make safer options faster and more accessible.
We are committed to
Guiding you to the genomic data you need to gather and store
Connecting you with expert providers to identify the best available and personalized treatment options for your genetically unique cancer
Providing guidance on gathering, storing, and interpreting data, and monitoring the status of your disease
Accelerating the adoption of the most advanced and sophisticated cancer treatments
We are committed to
Guiding you to the genomic data you need to gather and store
Connecting you with expert providers to identify the best available and personalized treatment options for your genetically unique cancer
Providing guidance on gathering, storing, and interpreting data, and monitoring the status of your disease
Accelerating the adoption of the most advanced and sophisticated cancer treatments
Our Vision
We envision a world in which all people with life-threatening diseases can use their genomic and health data as the catalyst toward optimal health and wellness.